# A Clinical Study of the HIV Drug CPT31 in Healthy Volunteers

> **NCT04672083** · PHASE1 · COMPLETED · sponsor: **Navigen, Inc.** · enrollment: 32 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** CPT31
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04672083
- **Lead sponsor:** Navigen, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-16
- **Primary completion:** 2021-04-26
- **Final completion:** 2021-04-29
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-02-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04672083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04672083, "A Clinical Study of the HIV Drug CPT31 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04672083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*